There’s no better way to drive trial of a product than placing that product in the consumer’s hands. Unless, of course, it’s a doctor placing that product in the consumer’s hands at the point of care, which is how Brandperx samples products.
ProPhase Labs on Monday again rejected an acquisition proposal from Matrixx Initiatives. Matrixx's latest offer was to acquire ProPhase for $1.60 per share in cash, up from a prior $1.40 per share proposal.
The lackluster cough-cold season will necessitate a greater need for marketing and promotion next season, ProPhase Labs chairman and CEO Ted Karkus said on Thursday in announcing first-quarter results for the period ended March 31.